Tofogliflozin a selective SGLT2 inhibitor exhibits highly favourable drug properties for use in patients with renal impairment and for combination with other medicines

D. Schwab, A. Portron, Y. Fukushima, Z. Backholer, O. Kuhlmann,T. Saito, S. Ikeda

DIABETOLOGIA(2012)

引用 1|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要